IMP3 Immunohistochemical Expression in Inverted Papilloma and Inverted Papilloma‐Associated Sinonasal Squamous Cell Carcinoma

SA Hakim, NM Abd Raboh… - Analytical Cellular …, 2021 - Wiley Online Library
Sinonasal inverted papilloma (IP) has a propensity for malignant transformation. Although
the IP‐associated squamous cell carcinoma (SCC) is rare, it has a poor prognosis. To the …

IMP3 and p16 expression in squamous cell carcinoma of the head and neck: A comparative immunohistochemical analysis

MO Riener, J Hoegel, H Iro… - Oncology …, 2017 - spandidos-publications.com
Expression of p16 has been established as a good surrogate marker for high-risk human
papillomavirus (HPV) infection in oropharyngeal squamous cell carcinoma (OPSCC) …

IMP3 protein overexpression is linked to unfavorable outcome in laryngeal squamous cell carcinoma

D Maržić, B Marijić, T Braut, S Janik, M Avirović… - Cancers, 2021 - mdpi.com
Simple Summary IMP3 expression was analyzed in patients with malignant (laryngeal
squamous cell carcinoma), semi-malignant (dysplasia) and benign (nodules, polyps) …

IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma

HG Li, JJ Han, ZQ Huang, L Wang… - Journal of …, 2011 - journals.lww.com
Insulinlike growth factor II mRNA-binding protein 3 (IMP3) is a newly identified mRNA-
binding protein that is involved in embryogenesis and carcinogenesis of some malignant …

Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma

K Chen, KM Cornejo, W Ye, Q Wu, J Liang, Z Jiang - Human Pathology, 2013 - Elsevier
An accurate diagnosis of laryngeal squamous cell carcinoma (LSCC) is essential for patient
management. The diagnosis of LSCC, especially in superficial biopsies, can present a …

[HTML][HTML] The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands

MR Elshafey, RA Ahmed, MI Mourad… - Cancer Biology & …, 2016 - ncbi.nlm.nih.gov
Objective: Mucoepidermoid carcinoma (MEC) is the most common primary malignancy of
the salivary glands. Insulin-like growth factor-II mRNA-binding protein-3 (IMP3) is an …

IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer

D Lu, X Yang, NY Jiang, BA Woda, Q Liu… - The American journal …, 2011 - journals.lww.com
The expression of IMP3, an oncofetal protein, has been strongly associated with aggressive
cancers. In this study, we investigated whether IMP3 can serve as a biomarker to predict …

[HTML][HTML] Prognostic Value of IMP3 Expression in Squamous Cervical Cancer

T Krešić, M Klarić, S Eminović, A Kolobarić… - Applied …, 2024 - journals.lww.com
Cervical cancer remains one of the leading causes of death from malignant diseases in
women worldwide. Primary and secondary prevention have led to better outcomes in …

IMP‐3 expression in melanocytic lesions

L Yu, H Xu, MJ Wasco, PA Bourne… - Journal of cutaneous …, 2010 - Wiley Online Library
Background: Insulin‐like growth factor‐II mRNA‐binding protein 3 (IMP‐3), a member of the
insulin‐like growth factor mRNA‐binding protein family, is expressed in several human …

IMP3 expression as a potential tumour marker in high-risk localisations of cutaneous squamous cell carcinoma: IMP3 in metastatic cSCC

M Klein, M Wefers, C Hallermann, HJ Fischer, F Hölzle… - Cancers, 2023 - mdpi.com
Simple Summary High IMP3 expression is correlated with poorer prognosis in many tumour
entities. To date, there have been no data on IMP3 expression and clinical outcome in high …